ZVRA — Zevra Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Zevra Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	4.21	112	82.8	67.7	69.5
Net Total Accounts Receivable
Net Total Receivables	2.58	1.53	8.3	17.4	10.5
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	8.38	115	92.8	86.9	86
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.39	2.02	1.78	1.53	1.01
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	11.2	133	115	172	178
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	7.54	4.23	12	73.7	34.1
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	77.6	5.82	40.2	110	138
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	-66.4	127	75.1	61.9	39.7
Total Liabilities & Shareholders' Equity	11.2	133	115	172	178
Total Common Shares Outstanding